Nicholas Arpaia
Impact in
- Biotechnology top 0.2%
- Cancer Research and Treatments
- Biological Psychiatry top 1%
Papers in
-
- Cancer Research and Treatments 10
- Immunology 13
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 5
- Immune Response and Inflammation 5
- T-cell and B-cell Immunology 4
- Co-authors
- Alexander Y. RudenskyStanislav DikiyHui LiuJoris van der VeekenPaul J. CofferJustin R. CrossClarissa CampbellXiying Fan
- Journals
- The Journal of Experimental Medicine (3 papers)Cancer Research (3 papers)Nature (2 papers)Cell (2 papers)Immunity (2 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Nicholas Arpaia
27 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Biotechnology 1.1k
- Biological Psychiatry 294
- Immunology 1.9k
- Gastroenterology 340
- Infectious Diseases 935
Countries citing papers authored by Nicholas Arpaia
This map shows the geographic impact of Nicholas Arpaia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Arpaia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Arpaia more than expected).
Fields of papers citing papers by Nicholas Arpaia
This network shows the impact of papers produced by Nicholas Arpaia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Arpaia. The network helps show where Nicholas Arpaia may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas Arpaia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 28 | |
| 3 | 2024 | 13 | |
| 4 | Probiotic neoantigen delivery vectors for precision cancer immunotherapy Hit paper breakdown → | 2024 | 70 |
| 5 | Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity Hit paper breakdown → | 2023 | 96 |
| 6 | Probiotic-guided CAR-T cells for solid tumor targeting Hit paper breakdown → | 2023 | 146 |
| 7 | 2023 | 7 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 34 | |
| 10 | A programmable encapsulation system improves delivery of therapeutic bacteria in mice Hit paper breakdown → | 2022 | 171 |
| 11 | 2022 | 43 | |
| 12 | Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies Hit paper breakdown → | 2020 | 420 |
| 13 | 2017 | 35 | |
| 14 | 2014 | 31 | |
| 15 | Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation Hit paper breakdown → | 2013 | 3510 |
| 16 | 2013 | 19 | |
| 17 | 2011 | 196 | |
| 18 | 2011 | 86 | |
| 19 | 2011 | 106 | |
| 20 | 2005 | 24 |
About Nicholas Arpaia
Nicholas Arpaia is a scholar working on Biotechnology, Immunology, Biological Psychiatry, Oncology and Ecology, having authored 30 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer Research and Treatments (10 papers), Immune Cell Function and Interaction (6 papers), Bacteriophages and microbial interactions (5 papers), Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (5 papers), Nanoplatforms for cancer theranostics (4 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Biotechnology (1.1k citations), Biological Psychiatry (294 citations), Immunology (1.9k citations), Gastroenterology (340 citations) and Infectious Diseases (935 citations). Nicholas Arpaia has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Alexander Y. Rudensky, Stanislav Dikiy, Hui Liu, Joris van der Veeken, Paul J. Coffer, Justin R. Cross, Clarissa Campbell, Xiying Fan, Paul deRoos and Klaus Pfeffer. Their work appears in journals such as The Journal of Experimental Medicine, Cancer Research, Nature, Cell and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.